tiprankstipranks
Advertisement
Advertisement

CTSO Stock Latest News

CytoSorbents trading halted, news pending
The FlyCytoSorbents trading halted, news pending
45m ago
CTSO
CytoSorbents announces 1-for-20 reverse stock split
PremiumThe Fly
CytoSorbents announces 1-for-20 reverse stock split
2d ago
CTSO
CytoSorbents announces real-world data using CytoSorb
PremiumThe Fly
CytoSorbents announces real-world data using CytoSorb
3d ago
CTSO
Cytosorbents Earnings Call Balances Progress and Risk
PremiumCompany Announcements
Cytosorbents Earnings Call Balances Progress and Risk
11d ago
CTSO
CytoSorbents Shareholders Approve Governance Measures and Reverse Split
PremiumCompany Announcements
CytoSorbents Shareholders Approve Governance Measures and Reverse Split
21d ago
8K
CTSO
Cytosorbents Advances Toward Operating Cash Flow Breakeven
PremiumCompany AnnouncementsCytosorbents Advances Toward Operating Cash Flow Breakeven
28d ago
8K
CTSO
CytoSorbents: Neutral Rating Reiterated as Operational Progress Offsets Market and Regulatory Risks; $0.75 Price Target Maintained
Premium
Ratings
CytoSorbents: Neutral Rating Reiterated as Operational Progress Offsets Market and Regulatory Risks; $0.75 Price Target Maintained
29d ago
CTSO
Is CTSO a Buy, Before Earnings?
Premium
Pre-Earnings
Is CTSO a Buy, Before Earnings?
1M ago
CTSO
Cytosorbents Faces Nasdaq Compliance and Delisting Risk
PremiumCompany Announcements
Cytosorbents Faces Nasdaq Compliance and Delisting Risk
2M ago
8K
CTSO
CytoSorbents Advances FDA Pathway for DrugSorb Programs
PremiumCompany Announcements
CytoSorbents Advances FDA Pathway for DrugSorb Programs
2M ago
8K
CTSO
Cytosorbents Earnings Call Balances Progress and Pressure
PremiumCompany Announcements
Cytosorbents Earnings Call Balances Progress and Pressure
4M ago
CTSO
Cytosorbents Earnings Call Balances Progress And Pressure
PremiumCompany Announcements
Cytosorbents Earnings Call Balances Progress And Pressure
4M ago
CTSO
CytoSorbents reports Q1 adjusted EPS (5c) vs. (6c) last year
PremiumThe FlyCytoSorbents reports Q1 adjusted EPS (5c) vs. (6c) last year
4M ago
CTSO
CTSO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CTSO Earnings this Week: How Will it Perform?
4M ago
CTSO
CytoSorbents Receives Nasdaq Extension to Regain Compliance
Premium
Company Announcements
CytoSorbents Receives Nasdaq Extension to Regain Compliance
5M ago
8K
CTSO
Cytosorbents’ Earnings Call Balances Progress and Risk
PremiumCompany Announcements
Cytosorbents’ Earnings Call Balances Progress and Risk
5M ago
CTSO
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
PremiumRatings
CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
5M ago
CTSO
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
PremiumCompany Announcements
CytoSorbents Narrows Losses Amid Strategic Shift and Growth
5M ago
8K
CTSO
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
PremiumThe Fly
CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year
5M ago
CTSO
CTSO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCTSO Upcoming Earnings Report: What to Expect?
6M ago
CTSO
CytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
Premium
The Fly
CytoSorbents sees Q4 revenue $9.2M, consensus $9.85M
8M ago
CTSO
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
Premium
The Fly
CytoSorbents sees FY25 revenue $37M, consensus $37.67M
8M ago
CTSO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >